%PDF-1.3
%
4 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\'g5 7︸C2Rlg炎/K9g560S.rLٸSnAWeUlb=)p
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\'g5 7︸C2Rlg炎/K9g560S.rLٸSnAWeUlb=)p
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\'g5 7︸C2Rlg炎/K9g560S.rLٸSnAWeUlb=)p
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\'g5 7︸C2Rlg炎/K9g560S.rLٸSnAWeUlb=)p
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\'g5 7︸C2Rlg炎/K9g560S.rLٸSnAWeUlb=)p
endstream
endobj
8 0 obj
<>stream
2020-06-16T21:17:35+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2020-06-24T16:52:01-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
MAB-2020-0011-ver9-Kato_3P 61..65
uuid:9d57730f-f339-4723-b414-294355b8241e
uuid:3432ed47-2775-4d8a-b345-9018a7d04d97
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
20 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(Materials)-332.7(and)-338.2(Methods)]TJ
/F10 1 Tf
0 -1.8336 TD
[(Cell)-336.3(line)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 692.9006 Tm
[(MIA)-275.8(PaC)11.9(a-2)-280.9(was)-281.6(ob)15.1(tai)12.6(ned)-280.9(fro)14(m)-290.3(t)0(h)15(e)-290.2(Cel)11.6(l)-289.2(R)0(e)12.9(sou)14.2(rce)-282.1(Cen)11.8(ter)]TJ
-1.0137 -1.1116 TD
[(for)-210.6(the)-206.2(Bio)12.8(me)12.7(dic)12.7(al)-216.6(Res)12(ea)12.8(rch)-211.8(Ins)14.2(tit)13.6(ute)-206.2(of)-215.3(De)13(vel)12.7(opm)12.8(ent)12.7(,)-216.5(Agi)13(ng)]TJ
0 -1.1174 TD
[(and)-211.8(Can)11.8(cer)-212.9(Toh)12.8(oku)-210.7(Uni)13(ve)13.9(rsit)18.6(y)-225.7(\()-75.9(Miy)12.9(agi)12.7(,)-216.5(Jap)13(an\))12.8(.)-222.3(MIA)-212.4(PaC)11.9(a-2)]TJ
0 -1.1116 TD
[(was)-581.1(cul)12.7(tur)13.9(ed)-579.3(in)-584.1(DME)11(M)-583.7(med)11.6(ium)-574.9(\(Na)12(cal)11.5(ai)-585.2(Tes)11.8(que)18.6(,)-590.9(Inc)12.9(.,)]TJ
T*
[(Kyo)13.1(to,)-241.9(Jap)13(an)13.9(\),)-246.4(sup)14.2(ple)12.7(men)11.6(ted)-240.7(wit)12.8(h)-248.8(10%)-240.5(he)13.9(at-)12.7(ina)12.7(cti)12.6(vat)12.7(ed)-245.3(fet)12.7(al)]TJ
0 -1.1174 TD
[(bov)14(ine)-188.9(ser)13(um)-187.7(\(Th)12.8(erm)11.6(o)-191.2(Fis)14.2(her)-188.7(Sci)12.8(ent)12.7(ic)12.9(,)-193.5(Inc)12.8(.,)-191.2(Wa)11.7(lth)13.7(am,)-186.6(MA\))12.2(,)]TJ
0 -1.1116 TD
[(100)-153.1(U/m)11.8(L)-561(o)0(f)-555.1(pen)12.8(ici)12.6(lli)13.6(n,)-557.5(10)15.1(0)]TJ
/F11 1 Tf
12.1991 0 TD
(l)Tj
/F3 1 Tf
.5472 0 TD
[(g/m)12.6(L)-561(o)0(f)-560.9(str)14.1(ep)13.9(tom)12.6(yci)12.7(n,)-557.5(and)]TJ
-12.7462 -1.1116 TD
[(0.2)11.6(5)]TJ
/F11 1 Tf
1.8949 0 TD
(l)Tj
/F3 1 Tf
.5472 0 TD
[(g/m)12.6(L)-232.7(o)0(f)-221(amp)11.6(hot)13.8(eri)12.7(cin)-217.7(B)-232.5(\(Na)12(cal)11.5(ai)-222.4(Tes)11.8(que)12.8(,)-228.1(Inc)12.9(.\))-223.4(at)-228.1(37)]TJ
/F5 1 Tf
20.7925 0 TD
()Tj
/F3 1 Tf
.3917 0 TD
(C)Tj
-23.6263 -1.1116 TD
[(in)-255.8(a)-261.4(hum)12.8(idi)13.7(ed)-252(atm)11.5(osp)14.2(he)13.9(re)-256.8(con)12.8(tai)12.6(nin)13.9(g)-260.3(5)0(%)-256.7(C)0(O)]TJ
7.3823 0 0 6.5614 244.8566 603.6093 Tm
(2)Tj
9.843 0 0 9.843 251.0928 605.2534 Tm
[(and)-252.1(95%)-252(air)12.7(.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 583.1432 Tm
(Animals)Tj
/F3 1 Tf
9.843 0 0 9.843 72 566.7022 Tm
[(All)-557.4(animal)-557.6(experiments)-558.3(were)-554.7(performed)-560.5(by)-555.1(following)]TJ
-1.0137 -1.1116 TD
[(relevant)-312(guidelines)-307.3(and)-309.7(regulations)-308.4(to)-307.6(minimize)-307.7(animal)-309.9(suf-)]TJ
0 -1.1174 TD
[(fering)-318.9(and)-309.7(distress)-320.6(in)-313.4(the)-315.6(laboratory.)-316.5(Animal)-315.4(studies)-314(for)-314.3(an-)]TJ
0 -1.1116 TD
[(titumor)-291.5(activity)-293.9(were)-295.6(approved)-293.3(by)-284.4(the)-292.6(Institute)-293.6(of)-290.2(Microbial)]TJ
T*
[(Chemistry)-203.4(\(Permit)-206(number:)-200.3(2019-021\).)-203.4(Mice)-203.6(were)-203.4(monitored)]TJ
0 -1.1174 TD
[(for)-337.3(health)-343.3(and)-338.5(weight)-337.2(every)-341.9(24)-337.4(days.)-342.9(The)-334(experiment)-344.3(was)]TJ
0 -1.1116 TD
[(conducted)-370.6(over)-362.6(three)-365(weeks.)-369(A)-364.8(bodyweight)-370.4(loss)-361.2(exceeding)]TJ
T*
[(25%)-303.9(and)-298.2(a)-301.8(maximum)-300.7(tumor)-306.3(size)-300.4(exceeding)-302.7(3000)-171.4(mm)]TJ
7.3823 0 0 6.5614 275.3007 494.3621 Tm
(3)Tj
9.843 0 0 9.843 281.9338 489.9967 Tm
(were)Tj
-22.3419 -1.1174 TD
[(identied)-427.2(as)-429.4(humane)-424.9(endpoints.)-429.3(Mice)-428.2(were)-428(euthanized)-430.6(by)]TJ
0 -1.1116 TD
[(cervical)-209.5(dislocation,)-208.3(and)-206.1(the)-206.2(death)-203.8(was)-206.7(veried)-205.8(by)-203.8(respiratory)]TJ
T*
[(arrest)-285.3(and)-280.9(cardiac)-283.2(arrest.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 435.0046 Tm
[(Flow)-338.7(cytometry)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 418.5637 Tm
[(MIA)-206.6(PaCa-2)-205.6(cells)-203.7(were)-209.2(harvested)-209.1(by)-203.8(being)-202.6(exposed)-211.4(briey)]TJ
-1.0137 -1.1116 TD
[(to)-768.4(0.25%)-763.4(trypsin/1)-165.6(mM)-770.4(ethylenediaminetetraacetic)-775.2(acid)]TJ
T*
[(\(EDTA;)-483.1(Nacalai)-485.8(Tesque,)-485.7(Inc.\).)-478.9(After)-485.7(washing)-482(with)-483.6(0.1%)]TJ
0 -1.1174 TD
[(bovine)-370.8(serum)-370.5(albumin)-373.2(in)-370.9(phosphate-buffered)-375.6(saline)-371.9(\(PBS\),)]TJ
0 -1.1116 TD
[(MIA)-483.1(PaCa-2)-482.1(cells)-480.2(were)-479.9(treated)-483.7(with)-483.6(1)]TJ
/F11 1 Tf
16.7377 0 TD
(l)Tj
/F3 1 Tf
.5529 0 TD
[(g/mL)-479.3(anti-HER2)]TJ
-17.2906 -1.1116 TD
(\(H)Tj
7.3823 0 0 6.5614 72.3968 362.1542 Tm
(2)Tj
9.843 0 0 9.843 76.0819 363.7983 Tm
[(Mab-19\))-412.9(for)-406.4(30)-411.1(minutes)-407.6(at)-412.4(4)]TJ
/F5 1 Tf
12.1184 0 TD
()Tj
/F3 1 Tf
.3917 0 TD
[(C)-411.1(and)-407.6(subsequently)-412.8(with)]TJ
-13.9385 -1.1174 TD
[(Alexa)-406.3(Fluor)-397.1(488-conjugated)-405(anti-mouse)-406.3(IgG)-401.6(\(1:1000;)-400.7(Cell)]TJ
0 -1.1116 TD
[(Signaling)-512.4(Technology,)-519.2(Inc.,)-512.4(Danvers,)-515.2(MA\).)-515.3(Fluorescence)]TJ
T*
[(microscopy)-354.3(data)-346.7(were)-353.2(collected)-349(using)-351(an)-348.9(EC800)-347.6(Cell)-346.7(Ana-)]TJ
0 -1.1174 TD
[(lyzer)-284.4(\(Sony)-281.8(Corp.,)-277.2(Tokyo,)-280.8(Japan\).)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 297.8645 Tm
[(Determination)-337.6(of)-330.4(the)-334.8(binding)-338.5(afnity)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 281.4236 Tm
[(MIA)-344.9(PaCa-2)-343.8(cells)-347.7(were)-347.4(suspended)-345.9(in)-342.1(100)]TJ
/F11 1 Tf
17.354 0 TD
(l)Tj
/F3 1 Tf
.5472 0 TD
[(L)-347.9(serially)-345.4(di-)]TJ
-18.9149 -1.1174 TD
[(luted)-300.7(H)]TJ
7.3823 0 0 6.5614 91.8425 268.781 Tm
(2)Tj
9.843 0 0 9.843 95.5275 270.4251 Tm
[(Mab-19)-302.4(\(6)-163.4(ng/mL100)]TJ
/F11 1 Tf
9.3077 0 TD
(l)Tj
/F3 1 Tf
.5529 0 TD
[(g/mL\),)-299.5(followed)-304.8(by)-295.9(the)-298.3(ad-)]TJ
-13.2646 -1.1116 TD
[(dition)-202.8(of)-198(Alexa)-204.7(Fluor)-201.3(488-conjugated)-209.2(anti-mouse)-198.9(IgG)-205.7(\(1:200;)]TJ
T*
[(Cell)-329.4(Signaling)-333.9(Technology,)-329.1(Inc.\).)-334.9(Fluorescence)-329.8(microscopy)]TJ
0 -1.1174 TD
[(data)-427.3(were)-428(collected)-429.7(using)-425.9(an)-423.8(EC800)-422.4(Cell)-427.3(Analyzer)-428(\(Sony)]TJ
0 -1.1116 TD
[(Corp.\).)-186.1(The)-190(dissociation)-188.5(constant)-184(\()]TJ
/F4 1 Tf
13.6044 0 TD
(K)Tj
/F3 1 Tf
7.3823 0 0 6.5614 202.507 224.9574 Tm
(D)Tj
9.843 0 0 9.843 207.8362 226.6015 Tm
[(\))-185.4(was)-183.7(obtained)-189.9(by)-186.5(tting)]TJ
-14.814 -1.1116 TD
[(binding)-330.5(isotherms)-328.9(to)-324.9(built-in)-331.8(one-site)-328(binding)-330.5(models)-325.7(using)]TJ
T*
[(GraphPad)-334.4(PRISM)-329.6(6)-329.4(softwa)-8.5(re)-325.9(\(GraphPad)-335.4(Software,)-337.9(Inc.,)-328.1(La)]TJ
0 -1.1174 TD
[(Jolla,)-280.9(CA\).)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 171.6661 Tm
[(Antitumor)-335.1(activity)-332.8(of)-336.7(H)]TJ
6.7246 0 0 5.9768 150.5763 170.1354 Tm
(2)Tj
8.9663 0 0 8.9663 154.2614 171.6661 Tm
[(Mab-19)-337.6(in)-330.2(the)-334.8(xenografts)]TJ
-10.2874 -1.2266 TD
[(of)-336.7(pancreatic)-333.6(cancers)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 144.2267 Tm
[(Sixteen)-292.4(6-week-old)-296.5(female)-299.4(BALB/c)-294.3(nude)-293.6(mice)-296.1(were)-295.6(pur-)]TJ
-1.0137 -1.1116 TD
[(chased)-223(from)-218.7(Charles)-224.1(River)-226.7(and)-217.6(used)-224.2(when)-219.5(they)-218.8(were)-226.4(7)-214.2(weeks)]TJ
T*
[(old.)-467.6(MIA)-471.6(PaCa-2)-470.6(cells)-468.7(\(0.3)-168(mL)-465.4(of)-468.7(1.33)]TJ
/F5 1 Tf
16.9623 0 TD
()Tj
/F3 1 Tf
.72 0 TD
(10)Tj
7.3823 0 0 6.5614 245.8771 126.7086 Tm
(8)Tj
9.843 0 0 9.843 254.1543 122.3433 Tm
[(cells/mL)-474.5(in)]TJ
-19.5196 -1.1174 TD
[(DMEM\))-608.4(were)-606.6(mixed)-607(with)-604.5(0.5)-166.9(mL)-603.6(BD)-603.1(Matrigel)-611.4(Matrix)]TJ
0 -1.1116 TD
[(Growth)-192.8(Factor)-193.2(Reduced)-190.8(\(BD)-195.2(Biosciences,)-193.9(San)-194.4(Jose,)-187.2(CA\),)-192.9(and)]TJ
T*
(100)Tj
/F11 1 Tf
1.6703 0 TD
(l)Tj
/F3 1 Tf
.5472 0 TD
[(L)-382.4(o)0(f)-388.1(this)-378.8(suspension)-386.1(\(5)]TJ
/F5 1 Tf
9.8145 0 TD
()Tj
/F3 1 Tf
.72 0 TD
(10)Tj
7.3823 0 0 6.5614 197.348 93.8268 Tm
(6)Tj
9.843 0 0 9.843 204.8314 89.4614 Tm
[(cells\))-383.3(was)-385.3(injected)-387.1(sub-)]TJ
-14.5087 -1.1174 TD
[(cutaneously)-205.7(into)-206.2(the)-200.4(left)-207.4(ank.)-198.9(After)-209.2(day)-200.3(1,)-206.1(100)]TJ
/F11 1 Tf
18.7766 0 TD
(l)Tj
/F3 1 Tf
.5529 0 TD
.2027 Tc
(gH)Tj
7.3823 0 0 6.5614 266.2865 76.8189 Tm
0 Tc
(2)Tj
9.843 0 0 9.843 269.9716 78.463 Tm
(Mab-19)Tj
-21.1266 -1.1116 TD
[(and)-200.3(control)-193.4(mouse)-203.5(IgG)-194.2(\(Sigma-Aldrich)-204.3(Corp.\))-194.2(in)-198.2(100)]TJ
/F11 1 Tf
21.1554 0 TD
(l)Tj
/F3 1 Tf
.5529 0 TD
[(L)-198.1(PBS)]TJ
-21.7083 -1.1116 TD
[(were)-261(given)-266(an)-256.8(intraperitoneal)-269.4(\(i.p.\))-259(injection)-266.2(into)-258.1(treated)-264.8(and)]TJ
25.504 67.9242 TD
[(control)-343.2(mice,)-345.6(respectively.)-344(Additional)-341.9(antibodies)-341.8(were)-347.4(then)]TJ
0 -1.1174 TD
[(injected)-306.4(on)-301.7(days)-304.9(6)-300.6(and)-304(14.)-305.1(Twenty)-303.7(days)-304.9(after)-301.6(cell)-306.5(implanta-)]TJ
0 -1.1116 TD
[(tion,)-365.2(all)-367.6(mice)-365.2(were)-370.4(euthanized)-367.3(by)-365.1(cervical)-370.8(dislocation,)-369.5(and)]TJ
T*
[(tumor)-582.8(diameters)-584.9(and)-580.4(volumes)-586(were)-583.5(determined)-580.4(using)-581.4(a)]TJ
T*
[(method)-285.6(previously)-282.9(described.)]TJ
7.3823 0 0 6.5614 430.1857 685.7006 Tm
(\(19\))Tj
/F10 1 Tf
8.9663 0 0 8.9663 313.0582 662.1731 Tm
[(Statistical)-342.4(analyses)]TJ
/F3 1 Tf
9.843 0 0 9.843 323.0361 645.7321 Tm
[(All)-390.3(data)-392.8(were)-393.5(expressed)-398.9(as)-389.1(mean)]TJ
/F5 1 Tf
13.9846 0 TD
()Tj
/F3 1 Tf
.72 0 TD
[(standard)-391.2(error)-392.5(of)-393.8(the)]TJ
-15.7182 -1.1116 TD
[(mean)-8(.)-752.2(Statistical)-759(analy)-8(sis)-751.8(testsANOVA)-767.4(and)-753.2(Tukey)]TJ
0 -1.1174 TD
[(Kramers)-577.4(test)-570.1(were)-572(performed)-577.8(using)-569.9(GraphPad)-570.5(Prism)-570.9(6)]TJ
0 -1.1116 TD
[(softwa)-8.5(re)-262.5(\(GraphPad)-260.6(Software,)-268.8(Inc.\).)]TJ
/F4 1 Tf
14.8082 0 TD
(p)Tj
/F5 1 Tf
.6681 0 TD
(<)Tj
/F3 1 Tf
.72 0 TD
[(0.05)-260.2(was)-264.3(adopted)-263.6(as)]TJ
-16.1963 -1.1116 TD
[(the)-286.8(level)-278.8(of)-284.4(statistical)-280.9(signicance.)]TJ
/F7 1 Tf
8.9663 0 0 8.9663 313.0582 579.7416 Tm
(Results)Tj
/F10 1 Tf
0 -1.8336 TD
[(Characterization)-341.5(of)-330.4(H)]TJ
6.7246 0 0 5.9768 397.9841 561.8266 Tm
(2)Tj
8.9663 0 0 8.9663 401.6692 563.3007 Tm
[(Mab-19)-337.6(against)-333.8(a)-333.2(pancreatic)]TJ
-9.8827 -1.2203 TD
[(cancer)-336.9(cell)-333(line)]TJ
/F3 1 Tf
9.843 0 0 9.843 323.0361 535.918 Tm
[(We)-679.5(rst)-678(measured)-687.2(the)-678.5(surface)-679.1(expression)-681.2(of)-681.8(HER2)]TJ
-1.0137 -1.1116 TD
[(by)-428.4(human)-422.6(pancreatic)-431.8(cell)-427.4(line)-426.3(MIA)-425.5(PaCa-2.)-427.9(As)-423.3(expected,)]TJ
0 -1.1174 TD
(H)Tj
7.3823 0 0 6.5614 320.1448 512.3337 Tm
(2)Tj
9.843 0 0 9.843 323.8865 513.9778 Tm
[(Mab-19)-434.9(recognized)-442(endogenous)-439.4(HER2)-439.5(of)-439.9(MIA)-437(PaCa-2)]TJ
-1.1001 -1.1116 TD
[(cells)-411.1(by)-399.6(ow)-401.4(cytometry)-411.1(\(Fig.)-399.4(1A\).)-405(We)-403(next)-403.1(examined)-411.1(the)]TJ
ET
q
236.706 0 0 377.858 314.419 113.216 cm
/Im1 Do
Q
BT
/F6 1 Tf
9.845 0 0 9.845 313.0582 96.4346 Tm
[(FIG.)-595.9(1.)]TJ
/F3 1 Tf
4.3765 0 TD
[(Characterization)-594.7(of)-595.1(H)]TJ
7.3837 0 0 6.5625 448.4975 94.7905 Tm
(2)Tj
9.845 0 0 9.845 452.1826 96.4346 Tm
[(Mab-19)-589.5(using)-592.3(ow)-596.7(cy-)]TJ
-14.1315 -1.0135 TD
(tometry)Tj
/F6 1 Tf
3.4033 0 TD
(\(A\))Tj
/F3 1 Tf
1.6585 0 TD
[(MIA)-275.3(PaCa-2)-279.8(cells)-272.4(were)-277.8(treated)-281.5(with)-275.8(H2Mab-19)]TJ
-5.0618 -1.0077 TD
[(and)-251.8(negative)-253.6(control)-250.3(\(blocking)-252.3(buffer\).)]TJ
/F6 1 Tf
15.8245 0 TD
(\(B\))Tj
/F3 1 Tf
1.5778 0 TD
[(Determination)-255.2(of)]TJ
-17.4023 -1.0135 TD
[(binding)-398.9(afnity)-399.9(of)-393.6(H)]TJ
7.3837 0 0 6.5625 398.7212 64.9134 Tm
(2)Tj
9.845 0 0 9.845 402.4062 66.5575 Tm
[(Mab-19)-399.5(for)-400.3(MIA)-396.2(PaCa-2)-400.7(cells)-399.1(using)]TJ
-9.0755 -1.0135 TD
[(ow)-337.6(cytometry.)]TJ
/F7 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(62)Tj
48.2754 0 TD
[(KATO)-330.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
23 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? 4E2M3KUQROg $VGK+;
C.
@|z3d3Ϳ~0ꑠIg7~?,J_-/aaPf mDMmO' 6|{k.mu嫍:#uqe ꠅ¨g|mOխ5Uaq
@[O3jul-5ŗ5KciaoH_b=ķEƲod'͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfS 97O6!M.ֆ_y:Vo_2i.S'Y.]"1q~W=r_4nԭze@>8c6I&mEλ+x]]H"G3|9Ky[Q|FjjGPO=G~| yI;Mr[h u M">cu
̗=d&jи&|fTsO 78Zv E?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6pϟʿ=~cyP*+N*ڍٞ4rH>V*%bBԜS__2oSO/iCJs0w+ŘP$ ^\ǖ?/VNEd9[H}ASjqvqCڙr_&jP"K[ɠX
MPڧ\Z(Gy<{=ncY/!pԏep_?+H!oRR^ܛkǥw>[n&noo'W["bARTu'YPևɦZptM͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6yQ
kj m <h6?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lKRG:FM6?ユ ,?mp~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰOɦzpM͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6yֿ
j~q &h6?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lKRG:FM6?ユ ,?mp~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٰΤ(kDulM Xٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa7
<4+@ 0 ɵf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfo:<7iV 7aa kf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf̈́u~?M6
?ユ ,?mp~lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lCk%ׅmH)ӛ"Fn<ƳD,q'!*dA=:>
?Zٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳa7+7iWL_A &͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛ _NQ Mt\6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l%ɶzpM͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6yҟ
j>q &h6?6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6~ZVXpJwpc$&t* f͛6lKQ_'}n?`8Zo &͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfo7御>m{FCBܘҕ4|g[{+]wqv7q#Mǚ@5+ޝ*P s6lٳa/ M6?ㅦ ,?mp~lƿ(?05 +>Nkqݡ .Qe{r+5ye6;gE[YJlv_!&vռSϺ\]v+TrV#a| 9m}yMSAJ?m亿fU=IxQ 9aTmu*&"^^& _:^ae}.%p. ~.-/γ a;Sk=GPRqckYciĞ'jn)uk-kH|a=a@"j
ʘ]u-{A-3WʣerU#瞑͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lʿ&<ߕ=Z[ל2 4j
4hZ